- Home
- UAN vs RLAY Comparison
UAN vs RLAY Comparison
Compare UAN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAN | RLAY |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2008 | 2020 |
Fundamental Metrics
Financial Performance| Metric | UAN | RLAY |
|---|---|---|
| Price | $129.22 | $9.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $16.14 |
| AVG Volume (30 Days) | 99.8K | ★ 2.2M |
| Earning Date | 04-27-2026 | 05-04-2026 |
| Dividend Yield | ★ 8.03% | N/A |
| EPS Growth | ★ 61.98 | 31.78 |
| EPS | ★ 9.33 | N/A |
| Revenue | ★ $606,038,000.00 | $15,355,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $396.00 |
| P/E Ratio | $14.18 | ★ N/A |
| Revenue Growth | 15.36 | ★ 53.44 |
| 52 Week Low | $63.45 | $1.78 |
| 52 Week High | $139.50 | $11.49 |
Technical Indicators
Market Signals| Indicator | UAN | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 58.87 | 50.91 |
| Support Level | $89.52 | $9.06 |
| Resistance Level | $139.50 | $11.46 |
| Average True Range (ATR) | 7.23 | 0.69 |
| MACD | 0.97 | -0.09 |
| Stochastic Oscillator | 68.95 | 27.57 |
Price Performance
Historical ComparisonAbout UAN CVR Partners LP
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).